Related Experiment Video
Updated: Jun 30, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Multimorbidity in patients with atrial fibrillation
Michelle Lobeek1, Melissa E Middeldorp1, Isabelle C Van Gelder1
1Department of Cardiology, UMCG, Groningen, The Netherlands.
Insights
Atrial fibrillation (AF) and multimorbidity are rising, straining healthcare systems. Effective management requires identifying comorbidities and integrated care strategies to improve patient outcomes and reduce risks.
Area of Science:
- Cardiology
- Geriatrics
- Public Health
Background:
- Atrial fibrillation (AF) incidence and prevalence are increasing globally.
- AF is frequently associated with multiple comorbidities, leading to multimorbidity.
- The rise in AF and multimorbidity places a significant burden on healthcare systems.
Purpose of the Study:
- To understand the relationship between multimorbidity and AF.
- To identify effective healthcare strategies for managing patients with AF and comorbidities.
- To improve patient outcomes and reduce the impact of AF-related complications.
Main Methods:
- Review of existing literature on AF, comorbidities, and multimorbidity.
- Analysis of the impact of multimorbidity on AF pathophysiology and perpetuation.
- Exploration of challenges in treating comorbidities in AF patients.
Main Results:
- Accurate identification of comorbidities is crucial for managing AF.
- Understanding the pathophysiology and interactions of comorbidities is essential.
- Integrated care and individualized approaches are needed for comprehensive multimorbidity management.
Conclusions:
- Managing comorbidities in AF is vital for reducing adverse events and hospitalizations.
- Future healthcare strategies must prioritize integrated care for multimorbidity in AF.
- Effective management can decrease AF-related frailty and cardiovascular disease risks.
Abstract:
There is an escalating trend in both the incidence and prevalence of atrial fibrillation (AF). AF is linked to numerous other comorbidities, contributing to the emergence of multimorbidity. The sustained rise in multimorbidity and AF prevalences exerts a significant strain on healthcare systems globally. The understanding of the relation between multimorbidity and AF is essential to determine effective healthcare strategies, improve patient outcomes to adequately address the burden of AF. It not only begins with the accurate identification of comorbidities in the setting of AF. There is also the need to understand the pathophysiology of the different comorbidities and their common interactions, and how multimorbidity influences AF perpetuation. To manage the challenges that rise from the increasing incidence and prevalence of both multimorbidity and AF, such as adverse events and hospitalisations, the treatment of comorbidities in AF has already gained importance and will need to be a primary focus in the forthcoming years. There are numerous challenges to overcome in the treatment of multimorbidity in AF, whereby the identification of comorbidities is essential. Integrated care strategies focused on a comprehensive multimorbidity management with an individual-centred approach need to be determined to improve healthcare strategies and reduce the AF-related risk of frailty, cardiovascular diseases and improve patient outcomes.
More Related Videos
Related Concept Videos
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Pathophysiology of Heart Failure
Mechanism of Cardiac Arrhythmias
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Heart Failure Drugs: β-Blockers

